|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/10 | |
| A61K 47/10 | |||
| A61K 31/5513 | |||
| A61P 25/18 | |||
| A61K 47/02 |
| (11) | Number of the document | 1646393 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04748853.1 |
| Date of filing the European patent application | 2004-07-22 | |
| (97) | Date of publication of the European application | 2006-04-19 |
| (45) | Date of publication and mention of the grant of the patent | 2013-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/NZ2004/000158 |
| Date | 2004-07-22 |
| (87) | Number | WO 2005/007168 |
| Date | 2005-01-27 |
| (30) | Number | Date | Country code |
| 52714203 | 2003-07-23 | NZ |
| (72) |
SURMAN, Peter William, NZ
HOULDER-LEVELL, Sharon, NZ
MAK, Wai Bik, NZ
MCLEOD, Andrew Douglas, NZ
|
| (73) |
Douglas Pharmaceuticals Limited,
Central Park Drive, Lincoln, Auckland,
NZ
|
| (54) | A STABLE CLOZAPINE SUSPENSION FORMULATION |
| A STABLE CLOZAPINE SUSPENSION FORMULATION |